Virbac (XPAR:VIRP) Change In Inventory : €-39 Mil (TTM As of Jun. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Virbac Change In Inventory?

Virbac's change in inventory for the quarter that ended in Jun. 2023 was €-9 Mil. It means Virbac's inventory increased by €9 Mil from Dec. 2022 to Jun. 2023 .

Virbac's change in inventory for the fiscal year that ended in Dec. 2022 was €-56 Mil. It means Virbac's inventory increased by €56 Mil from Dec. 2021 to Dec. 2022 .

Virbac's Total Inventories for the quarter that ended in Jun. 2023 was €341 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Virbac's Days Inventory for the quarter that ended in Jun. 2023 was 293.27.

Inventory Turnover measures how fast the company turns over its inventory within a year. Virbac's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.62.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Virbac's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.55.

Virbac Change In Inventory Historical Data

The historical data trend for Virbac's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Change In Inventory Chart

Virbac Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

-12.64

-9.07

-22.09

-54.26

-55.77

Virbac Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Inventory	Get a 7-Day Free Trial															-27.48	-26.79	-25.99	-29.78	-9.20

Virbac Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-39 Mil.

Virbac (XPAR:VIRP) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Virbac's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	336.082	/	209.141	*	365 / 2
	=	293.27

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Virbac's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	209.141	/	336.082
	=	0.62

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Virbac's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	336.082	/	610.468
	=	0.55

Virbac Change In Inventory Related Terms

Thank you for viewing the detailed overview of Virbac's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac (XPAR:VIRP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (XPAR:VIRP) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

0NM7:UK V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.

Virbac (XPAR:VIRP) Headlines

No Headlines